Tue.Nov 21, 2023

article thumbnail

Invisible in the data: Broad ‘Asian American’ category obscures health disparities

STAT

They have roots in 50 countries that cover more than half of the globe’s surface. They make up more than 60% of the world’s population. They speak more than 100 different languages. Yet in medical research and public health in the United States, people with Asian ancestry are almost always grouped into a single racial category. Nearly 25 million Americans — from Hmong to Laotians, and Koreans to Indonesians — have been given the same label by the U.S. government despi

Labelling 364
article thumbnail

The biopharma COO’s playbook

PharmaVoice

Connie Chang, COO at ONL Therapeutics, describes what it takes to bring a CEO’s vision to life.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: Filling 12-month prescriptions is one practical way to help the pharmacist crisis

STAT

Pharmacies could be called the most “rock solid” entity in our health care system. Even before Covid, pharmacies were held in high esteem; during the pandemic, they raised their game by making it easy for tens of millions of Americans to get vaccinated, fulfilling a long-standing ambition of pharmacists to provide more expansive clinical services.

Vaccines 357
article thumbnail

Texas AG sues Pfiz­er and Tris Phar­ma for adul­ter­at­ed ADHD drug

Pharmaceutical Technology

Texas AG has sued Pfizer and Tris Pharma for providing adulterated attention-deficit/hyperactivity disorder drug, Quillivant XR, to children.

141
141
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: What Rosalynn Carter understood about mental health

STAT

Few people leave the world with as much grace or influence as Rosalynn Smith Carter, who died Sunday at the age of 96. While she called her autobiography “The First Lady of Plains,” to many she was also the first lady of mental health reform. Decades ago, she took bold stances on mental health topics that, today, have become conventional wisdom: Mental health is health, stigma is deadly, and people with mental illness deserve to be part of society instead of hidden away in overcrow

354
354
article thumbnail

Roche’s Genentech partners with Nvidia in AI drug deal

BioPharma Dive

The partnership is another investment by the biotech subsidiary in artificial intelligence for drug discovery and development, continuing an industry trend.

129
129

More Trending

article thumbnail

GSK propels its progress to Net Zero

European Pharmaceutical Review

Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. The pharma company stated that if successful, it has the potential to reduce greenhouse gas emissions from use of the inhaler by approximately 90 percent. According to GSK, thirty-five million patients with respiratory conditions globally relying on its metered dose inhaler.

116
116
article thumbnail

STAT+: Delay of eye drop recall highlights FDA’s impotence on the issue

STAT

WASHINGTON — It took nearly three weeks for a maker of eye drops to recall its products after the Food and Drug Administration requested a recall. There have been no reports of injuries, but some key lawmakers are arguing the time it took the FDA to coax a voluntary recall shows the agency should be given the power to force them. Eye drops must be sterile because drugs applied to eyes bypass some of the body’s natural defenses.

327
327
article thumbnail

Quotient emerges from Flagship with plan to explore somatic mutations

BioPharma Dive

Studying somatic mutations could be “the next wave of opportunity” to develop more precise medicines, said Mike Stratton, one of Quotient’s scientific co-founders.

111
111
article thumbnail

STAT+: How the CEO of the largest medical device accelerator molds medtech startups

STAT

If Paul Grand weren’t the CEO of MedTech Innovator, the largest medical device accelerator in the world, he might have been a keychain salesman. Maybe a producer of the X-Files. Or even invented Quizlet. The son of a teacher and a dentist, Grand graduated from selling neighbors keychains and washing cars as a little kid to programming software that made his parents’ lives easier.

336
336
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Two charities co-fund £5.5m childhood cancer research programme

Pharma Times

SMPaeds2 aims to advance precision medicines for children with relapsed cancer - News - PharmaTimes

137
137
article thumbnail

STAT+: Flagship Pioneering launches Quotient, a new biotech, in two countries

STAT

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom. Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age.

Diabetes 278
article thumbnail

Lab-grown blood vessels could potentially treat strokes and vascular dementia

Pharma Times

Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes - News - PharmaTimes

130
130
article thumbnail

STAT+: Mixed study results for MorphoSys blood-cancer drug raise questions about approval

STAT

LONDON — An experimental blood cancer drug from MorphoSys hit its primary target in a pivotal trial, the company announced late Monday, but the drug faltered in addressing patient symptoms, causing the company’s stock to fall in early Tuesday trading. In the Phase 3 trial, the German company was testing its drug candidate pelabresib combined with the drug Jakafi against a Jakafi-placebo duo in patients with newly diagnosed myelofibrosis, a type of rare blood cancer.

289
289
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

BRUKINSA® granted significant EU approval in follicular lymphoma

European Pharmaceutical Review

BRUKINSA ® (zanubrutinib) in combination with the anti-CD20 monoclonal antibody obinutuzumab, has been approved by the European Commission (EC) to treat relapsed or refractory follicular lymphoma in individuals who have received at least two prior lines of systemic therapy. The oral treatment is now “the first Bruton’s tyrosine kinase (BTK) inhibitor approved in this indication and has the broadest label of any medicine in its class globally,” stated Dr Mehrdad Mobasher, Chief Medical Officer, H

article thumbnail

STAT+: Pharmalittle: Texas sues Pfizer over ADHD drugs; Merck buys a neuro startup

STAT

Hello, everyone. Damian Garde here, filling in for Ed Silverman on what is an abbreviated work week here in the U.S., where the holiday discourse has pivoted from how to deal with quarrelsome relatives to whether a certain overexposed obesity treatment is ruining the apparently hallowed tradition of consuming more food than you need. If your personal geography spares you from all this, perhaps consider giving some thanks.

272
272
article thumbnail

Medtronic CEO downplays impact of obesity drugs on procedures, devices

BioPharma Dive

Surging demand for GLP-1 agonists has put medtech firms like Medtronic under pressure, even as they argue the hit to their businesses will be minimal.

108
108
article thumbnail

Bayer’s new CEO was dealt a duo of ‘clearing events.’ Tough choices lie ahead

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at an ambitious genomics startup, some cautious optimism on Wall Street, and a rough day for an American in Germany.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Immunometabolism: Providing a new era of targeted medicine

pharmaphorum

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that specialises in immunometabolism – a rapidly emerging and exciting area of investigation into the role of intracellular metabolic pathways in immune cells.

Immunity 113
article thumbnail

More focus on precision medicine than ever before and what makes iSpecimen different

Outsourcing Pharma

OSP had a discussion with Tracy Curley, CEO of iSpecimen, and Eric Langlois, chief revenue officer of iSpecimen and Michael Howell,founder of Mountaineer Biosciences, Inc. to discuss a number of issues those working in precision medicine still face.

95
article thumbnail

Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced neutropenia

Express Pharma

Evive Biotech (Evive), a subsidiary of Yifan Pharmaceutical Co, and Acrotech Biopharma (Acrotech), a wholly-owned subsidiary of Aurobindo Pharma USA, announced that the US Food and Drug Administration (FDA) approved Ryzneuta (Efbemalenograstim alfa) indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutrop

article thumbnail

Pfizer and Astellas' prostate cancer drug for previously treated patients approved by FDA

Outsourcing Pharma

Astellas Pharma Inc. and Pfizer Inc. today announced that the companies received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application for small-molecule drug Xtandi (enzalutamide).

90
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Call for strengthening of education on antimicrobial resistance and stewardship

The Pharmacist

More work needs to be done to equip pharmacists and their teams with the knowledge, skills and attitudes to mitigate the threat of antimicrobial resistance (AMR) and foster antimicrobial stewardship (AMS), the International Pharmaceutical Federation (FIP) has said in a new report. Published to coincide with World Antimicrobial Resistance Awareness Week (18-24 November), the ‘Antimicrobial […] The post Call for strengthening of education on antimicrobial resistance and stewardship appeared

99
article thumbnail

CluePoints wins prestigious accolade for commitment to innovation and education

Outsourcing Pharma

CluePoints, a company providing risk-based study execution (RBx) and risk-based quality management (RBQM) software for clinical trials has won the best Contract Research Organization (CRO) in the specialist providers category at Citelineâs 2023 SCRIP Awards.

90
article thumbnail

VPAG rebate calculations risk NHS drug shortages, warns BGMA

The Pharmacist

The British Generic Manufacturers Association (BGMA) has questioned the detail of the newly agreed voluntary scheme for branded medicines pricing, access and growth (VPAG), warning that price erosion calculations could damage competition and lead to drug shortages. The government hailed the new VPAG agreement with NHS England and the Association of the British Pharmaceutical Industry […] The post VPAG rebate calculations risk NHS drug shortages, warns BGMA appeared first on The Pharmacist.

99
article thumbnail

Pfizer and Astellas' XTANDI® approved by U.S. FDA in earlier prostate cancer treatment setting

World Pharma News

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Pfizer Inc. (NYSE: PFE) announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Application for XTANDI® (enzalutamide), following FDA expedited development and review programs (Priority Review designation, Fast Track designation, Real-time Oncology Review), based on results from the Phase 3 EMBARK trial.

93
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA delays assessment of BMS and 2seventy’s CAR-T therapy

Pharmaceutical Technology

The FDA's decision on the sBLA for Abecma will be delayed beyond the set PDUFA target date of 16 December.

98
article thumbnail

Almirall and Absci partnership will help deliver life-changing medicines

Outsourcing Pharma

A partnership combining an integrated drug creation platform with a company specializing in dermatological expertise will deliver life-changing medicines to patients.

80
article thumbnail

UK launches medicines scheme with £400m earmarked for clinical trials

Pharmaceutical Technology

The new scheme will launch in 2024 and aims to save the National Health Service (NHS) £14bn over five years.

98
article thumbnail

An Examination of US Drug Shortages’ Impact on the Supply Chain

Pharmaceutical Commerce

IQVIA report explores why these shortages are increasing, and how they can be mitigated.

104
104
article thumbnail

Digital measures for value-based healthcare: Current perspectives

pharmaphorum

Digital measures for value-based healthcare: Current perspectives Mike.

115
115